CD109 and neoplasm: Similar signaling pathways have been observed in tumor cells, where FLOT2 upregulates CD109 by stabilizing the expression of STAT3, inhibiting the TGF-β signaling pathway and promoting the development of nasopharyngeal carcinoma.[43]